FDA Inspection 1276636 — Colgate-Palmolive India Ltd.

Colgate-Palmolive India Ltd. — FEI 3004698222

The FDA completed an inspection of Colgate-Palmolive India Ltd. on Jul 25, 2025 in Mumbai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 25, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mumbai (India)

Citations

IDCFRDescription
192021 CFR 211.166(a)(3)Valid stability test methods

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.